January 16, 2017 — Qaelum NV announced recently that they have entered into a partnership to bring the VirtualDose computed tomography (CT) organ dose tool to the Qaelum radiation dose monitoring solution, DOSE.
With increasing awareness of the risk of radiation dose, patient safety is a high priority in medical imaging departments. Radiation dose during medical examination can be optimized and monitored by DOSE, one of the total quality monitoring solutions of Qaelum, a KULeuven spinoff.
As the different organs of a human body are of variable dimensions and variable tissue composition, specifying organ radiation dose requires models that take all these variables into account.
This agreement makes the Virtual Patient technology — a family of anatomically correct phantoms, advanced GPU-based Monte Carlo simulation and software-as-a-service (SaaS) programming techniques — available to Qaelum customers. It enables users to accurately compute doses to radiosensitive organs for a broad range of the patient population, including those outside the “average” body size, and pediatric patients from newborn through adolescence. The VirtualDoseCT calculation engine integrates seamlessly with the Qaelum software, providing improved information without extra effort on the part of the user.
For more information: www.qaelum.com
April 15, 2026 
